Thermo Fisher Scientific Announces Collaboration with Celltrio to Unlock Fully Automated Cell Line Production

Thermo Fisher Scientific, the world leader in serving science, and Celltrio, a leading manufacturer of robotics-based solutions for the life sciences industry, have announced their collaboration to bring a fully automated cell culture system to biotherapeutics customers.

RoboCell cell line automation platform. Image Credit: Thermo Fisher Scientific

The collaboration will integrate the Thermo Scientific Momentum workflow scheduling software with the Celltrio RoboCell cell line automation platform to address the critical unmet market need for high-throughput automated cell line culturing and maintenance. Celltrio’s RoboCell systems distributed in Europe will now use Momentum software for work scheduling and data management. Thermo Fisher will also immediately take on exclusive responsibility for sales, installation, and support of the RoboCell system in Europe, with the possibility of extending into other geographies in the future.

"Cell line scale-up challenges have long stifled the full potential of biotherapy research. While researchers have been able to automate some aspects of cell line production, full automation has been well out of reach," said Hansjoerg Haas, senior director and general manager, laboratory automation, Thermo Fisher Scientific. "By collaborating with Celltrio, we’re bringing together the capabilities that make fully automated cell line culturing a reality. With the ability to effectively scale processes, biotherapeutics customers can focus on getting their innovative therapies to patients, paving the way to a better, healthier world."

Charlie Duncheon, CEO and co-founder, Celltrio, Inc. said, "The complementary expertise of Thermo Fisher and Celltrio offers a clear, powerful opportunity to help customers overcome a pressing roadblock. By offering Thermo Fisher’s intuitive Momentum workflow scheduling software with Celltrio’s end-to-end automation RoboCell platform, we can expand the RoboCell reach and amplify the impact of both solutions for biotherapeutics customers, benefitting the biopharma market and human health."

With the Momentum workflow scheduling software, RoboCell users may define, execute, and monitor processes and workflows with an easy-to-use interface. The software’s intelligent data-driven decision-making capabilities and bi-directional communication also enable secure connectivity and traceability while ensuring laboratories boost their performance.

For more information about the Thermo Scientific Momentum Workflow Scheduling Software, please visit: https://www.thermofisher.com/order/catalog/product/MOMENTUM

For more information about the Celltrio RoboCell cell line automation platform, please visit: https://www.celltrio.com/robocell ​​​​​​​

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2023, February 06). Thermo Fisher Scientific Announces Collaboration with Celltrio to Unlock Fully Automated Cell Line Production. AZoRobotics. Retrieved on June 22, 2024 from https://www.azorobotics.com/News.aspx?newsID=13572.

  • MLA

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific Announces Collaboration with Celltrio to Unlock Fully Automated Cell Line Production". AZoRobotics. 22 June 2024. <https://www.azorobotics.com/News.aspx?newsID=13572>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific Announces Collaboration with Celltrio to Unlock Fully Automated Cell Line Production". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=13572. (accessed June 22, 2024).

  • Harvard

    Thermo Fisher Scientific Inc.. 2023. Thermo Fisher Scientific Announces Collaboration with Celltrio to Unlock Fully Automated Cell Line Production. AZoRobotics, viewed 22 June 2024, https://www.azorobotics.com/News.aspx?newsID=13572.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.